Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pratesi

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatinC Manzotti, G Pratesi, E Menta, et al.
Birth Defects Original Article Series|January 1, 1982
beta-Thalassemia in Southern Italy: a preliminary approachL Tentori, M Marinucci, A Massa, et al.
British Journal of Cancer|September 2, 1999
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenograftsG Pratesi, P Perego, D Polizzi, et al.
Cancer Research|August 17, 2001
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell lineP Perego, M De Cesare, P De Isabella, et al.
Cancer Research|October 5, 2001
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecinM De Cesare, G Pratesi, P Perego, et al.
British Journal of Cancer|January 14, 2010
In vivo effects of rosiglitazone in a human neuroblastoma xenograftI Cellai, G Petrangolini, M Tortoreto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenograftsG Pratesi, M De Cesare, C Caserini, et al.
Scientific Reports|August 21, 2021
Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hoursG Venoso, A Iacoponi, G Pratesi, et al.
Biochemical Pharmacology|March 7, 2001
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesF Arcamone, F Animati, M Bigioni, et al.
Journal of Medicinal Chemistry|September 21, 2001
Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activityS Dallavalle, A Ferrari, B Biasotti, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatinC Manzotti, G Pratesi, E Menta, et al.
Birth Defects Original Article Series|January 1, 1982
beta-Thalassemia in Southern Italy: a preliminary approachL Tentori, M Marinucci, A Massa, et al.
British Journal of Cancer|September 2, 1999
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenograftsG Pratesi, P Perego, D Polizzi, et al.
Cancer Research|August 17, 2001
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell lineP Perego, M De Cesare, P De Isabella, et al.
Cancer Research|October 5, 2001
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecinM De Cesare, G Pratesi, P Perego, et al.
British Journal of Cancer|January 14, 2010
In vivo effects of rosiglitazone in a human neuroblastoma xenograftI Cellai, G Petrangolini, M Tortoreto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenograftsG Pratesi, M De Cesare, C Caserini, et al.
Scientific Reports|August 21, 2021
Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hoursG Venoso, A Iacoponi, G Pratesi, et al.
Biochemical Pharmacology|March 7, 2001
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesF Arcamone, F Animati, M Bigioni, et al.
Journal of Medicinal Chemistry|September 21, 2001
Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activityS Dallavalle, A Ferrari, B Biasotti, et al.
Pageof 17